News
Important Only
Airnexis Therapeutics Raises $200 Million Series A
Jan 9 (Reuters) - AIRNEXIS THERAPEUTICS LAUNCHES WITH $200M SERIES A TO ADVANCE PHASE 2 DUAL PDE3/4 INHIBITOR AN01 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)AIRNEXIS THERAPEUTICS: OVER-SUBSCRIBED SERIES A WAS LED BY FRAZIER LIFE SCIENCESFurther company coverage: [ ]Reuters
Fri, Jan 9
Revvity Collaborates With Lilly To Expand Access To Ai Drug Discovery Models
Jan 9 (Reuters) - Revvity Inc RVTY.N:REVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY INC: COLLABORATION FUNDS PARTICIPATING BIOTECHS TO ACCESS LILLY PREDICTIVE MODELS THROUGH REVVITY SIGNA...Reuters
Fri, Jan 9
Koppers Announces Retirement Of Chief Financial Officer Jimmi Sue Smith
Jan 9 (Reuters) - Koppers Holdings Inc KOP.N:KOPPERS ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER JIMMI SUE SMITHKOPPERS HOLDINGS INC - BRADLEY PEARCE ELECTED AS INTERIM CFO AND CHIEF ACCOUNTING OFFICERKOPPERS HOLDINGS INC - JIMMI SUE SMITH TO CONTINUE AS TREASURER UNTIL FEBRUARY 28, 2026Reuters
Fri, Jan 9
Oncoclinicas says its CEO succession talks at advanced stage
SAO PAULO, Jan 9 (Reuters) - Brazilian healthcare firm Oncoclinicas ONCO3.SA said on Friday it was at an advanced stage in the process of selecting a new chief executive, but did not give any details of potential candidates.The company was responding to a report published on Thursday by news outlet ...Reuters
Fri, Jan 9
DeepSeek to launch new AI model focused on coding in February, The Information reports
Jan 9 (Reuters) - Chinese AI startup DeepSeek is expected to launch its next-generation AI model V4 that features strong coding capabilities in February, The Information reported on Friday, citing people familiar with the matter. Reuters could not immediately verify the report.Reuters
Fri, Jan 9
Bragg Gaming Further Extends Pam Agreement With Entain
Jan 9 (Reuters) - Bragg Gaming Group Inc BRAG.TO:BRAGG GAMING FURTHER EXTENDS PAM AGREEMENT WITH ENTAINBRAGG GAMING GROUP INC - BETCITY.NL TO USE BRAGG'S PAM PLATFORM UNTIL MAY 2026BRAGG GAMING GROUP INC - EXPECTED TO MATERIALLY CONTRIBUTE TO REVENUESReuters
Fri, Jan 9
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter Results
Jan 9 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O:RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY, UNAUDITED FOURTH QUARTER AND FULL YEAR 2025 NET PRODUCT REVENUES AND UPCOMING MILESTONESRHYTHM PHARMACEUTICALS INC - MARCH 20, 2026 PDUFA GOAL DATE FOR SNDA FOR SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OB...Reuters
Fri, Jan 9
Gold Reserve Provides Update In Citgo Sale Process Gold Reserve Files Appeal
Jan 9 (Reuters) - Gold Reserve Ltd GRZ.V:GOLD RESERVE PROVIDES UPDATE IN CITGO SALE PROCESS: GOLD RESERVE FILES APPEALGOLD RESERVE LTD - FILES APPEAL WITH U.S. COURT OF APPEALSGOLD RESERVE LTD - COURT APPROVES SALE $2 BILLION LOWER THAN GOLD RESERVE BIDGOLD RESERVE: AS SITUATION IN VENEZUELA CONTINU...Reuters
Fri, Jan 9
Germany plans measures to combat harmful AI image manipulation
BERLIN, Jan 9 (Reuters) - Germany's justice ministry plans to present measures in the near future that would allow authorities to more effectively combat the use of artificial intelligence to manipulate images in ways that violate personal rights, a spokesperson said on Friday. Grok, the built-i...Reuters
Fri, Jan 9
Cloudforce Secures $10 Million Series A From Owl Ventures And Microsoft
Jan 9 (Reuters) - Microsoft Corp MSFT.O:CLOUDFORCE SECURES $10M SERIES A FROM OWL VENTURES AND MICROSOFT TO DEMOCRATIZE SAFE, EQUITABLE AI IN EDUCATION, HEALTHCARE, AND BEYONDCLOUDFORCE: FUNDING ROUND LED BY OWL VENTURES & PARTICIPATION FROM M12, MICROSOFT'S VENTURE FUNDReuters
Fri, Jan 9
Newamsterdam Pharma Highlights 2025 Achievements And Outlines 2026 Strategic Priorities
Jan 9 (Reuters) - NewAmsterdam Pharma Company NV KH6.F:NEWAMSTERDAM PHARMA HIGHLIGHTS 2025 ACHIEVEMENTS AND OUTLINES 2026 STRATEGIC PRIORITIESNEWAMSTERDAM PHARMA COMPANY NV - EMA APPROVAL DECISION FOR OBICETRAPIB EXPECTED IN H2 2026NEWAMSTERDAM PHARMA COMPANY NV - RUBENS PHASE 3 TRIAL EXPECTED TO EN...Reuters
Fri, Jan 9
